Magnifying LeNS Archives - GO2 for Lung Cancer

Do I Need Another Test? The Importance of Repeat Biomarker Testing in NSCLC

Bethany Johnson (GO2 for Lung Cancer)2024-02-22T09:35:55-06:00February 22nd, 2024|Hot Topics, Magnifying LeNS, Newsletter Articles|

Author: Brittney Nichols, MPH, BSN-RN, Senior Specialist, Science & Research, GO2 for Lung Cancer Biomarker testing is an important part of the cancer diagnosis and care continuum. For almost all people diagnosed with non-small cell lung cancer (NSCLC) biomarker [...]

0

Unleashing Precision: AI’s Promising Role in Revolutionizing Lung Cancer Care

Bethany Johnson (GO2 for Lung Cancer)2024-02-22T09:40:10-06:00February 22nd, 2024|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Author: Matthew Reiss, MSE, PhD, Manager, Precision Medicine & Navigation, GO2 for Lung Cancer You’ve likely started to see artificial intelligence (AI) being used more and more in your everyday life. While the benefits and challenges of using AI [...]

0

Antibody-Drug Conjugates (ADCs): A Promising Treatment for Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2024-02-22T09:39:27-06:00February 22nd, 2024|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Author: Renee Botello, MSc, Navigator, Treatment and Trials, GO2 for Lung Cancer With decades of research and advances in precision medicine, scientists continue to broaden the treatment standards and options for patients with non-small cell lung cancer (NSCLC). By [...]

0

Treatments, Trials, and Technology in Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2023-10-23T10:22:21-05:00October 23rd, 2023|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research, Small Cell Lung Cancer|

Author: GO2 for Lung Cancer Specialist, Science & Research, Brittney Nichols MPH, BSN-RN Each year, scientists and doctors from across the globe gather at IASLC’s World Conference on Lung Cancer (WCLC) to discuss the latest and greatest in lung [...]

1

New Clinical Trial Designs in the Era of Precision Medicine

Bethany Johnson (GO2 for Lung Cancer)2023-11-20T10:20:27-06:00October 23rd, 2023|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Author: GO2 for Lung Cancer Associate Director, Clinical Research, Andrew Ciupek, PhD With an increasing number of targeted therapies becoming available, making treatment decisions based on the results of biomarker testing has become an essential part of cancer care [...]

0

Addressing the Unmet Needs of Family Caregivers of People with Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2023-10-23T10:15:06-05:00October 23rd, 2023|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Author: Lung Cancer Registry Associate Director, Heather Law, MA Family caregivers often experience emotional distress and neglect their own well-being while caring for a loved one. Preliminary findings from GO2’s Lung Cancer Registry Caregiver Survey were presented at the 2023 World Conference on [...]

0

Perspectives from Providers, Patient Advocates, and People Living with Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2023-10-23T10:15:04-05:00October 23rd, 2023|Magnifying LeNS, Newsletter Articles, Science and Research|

Author: GO2 for Lung Cancer's Specialist, Science & Research, Brittney Nichols MPH, BSN-RN The IASLC annual World Conference on Lung Cancer (WCLC) unites lung cancer professionals from across the world to connect and share insights. This goes beyond the [...]

0

Lung Cancer After Tagrisso Resistance: What Next?

Bethany Johnson (GO2 for Lung Cancer)2023-10-23T10:14:51-05:00October 23rd, 2023|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

Author: GO2 for Lung Cancer Treatment and Trials Navigator, Renee Botello MSc Tagrisso (osimertinib) has been the treatment of choice and effective standard of care option for the treatment of EGFR+ non-small cell lung cancer (NSCLC) since its FDA [...]

2

ASCO 2023: Surviving and Thriving with Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2023-07-25T15:07:02-05:00July 25th, 2023|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

By Brittney Nichols, MPH, RN-BSN, Science and Research Specialist, GO2 for Lung Cancer New treatments, developments, and scientific breakthroughs are always one of the most exciting aspects of the annual American Society of Clinical Oncology (ASCO) conference, but this [...]

1

ASCO 2023: Progress for Metastatic (Stage 4) Non-Small Cell Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2023-07-25T15:04:43-05:00July 25th, 2023|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

By Andrew Ciupek, PhD, Associate Director, Clinical Research, GO2 for Lung Cancer New research on metastatic (stage 4) non-small cell lung cancer (NSCLC) was a hot topic at the 2023 American Society of Clinical Oncology (ASCO) meeting. Data from [...]

2